Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden

被引:11
作者
Bordas, Pal [1 ,2 ]
Jonsson, Hakan [2 ]
Nystrom, Lennarth [3 ]
Lenner, Per [2 ]
机构
[1] Sunderby Hosp, Dept Radiol, Norrbotten Mammog Screening Programme, SE-97180 Lulea, Sweden
[2] Umea Univ, Dept Radiat Sci, Umea, Sweden
[3] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
关键词
NEW-SOUTH-WALES; BREAST-CANCER; WOMEN; SURVIVAL; TRIAL;
D O I
10.1258/jms.2009.008098
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives To estimate the interval cancer incidence, its determinants and the episode sensitivity in the Norrbotten Mammography Screening Programme (NMSP). Setting Since 1989, women aged 40-74 years (n = 55,000) have been invited to biennial screening by the NMSP, Norrbotten county, Sweden. Methods Data on 1047 invasive breast cancers from six screening rounds of the NMSP (1989-2002) were collected. We estimated the invasive interval cancer rates, rate ratios and the episode sensitivity using the detection and incidence methods. A linear Poisson-model was used to analyse association between interval cancer incidence and sensitivity. Results 768 screen-detected and 279 interval cancer cases were identified. The rate ratio of interval cancer decreased with age. The 50-59 year age group showed the highest rate ratio (RR 0,52, 95% CI 0.41-0.65) and the 70-74 year age group the lowest (RR = 0.23, 95% Cl 0.15-0.36). The rate ratios for the early (0-12 months) and late (13-24 months) interval cancers were similar (RR = 0.18, 95% Cl 0.15-0.22 and 0.20, 95% CI 0.17-0.24). There was a significantly lower interval cancer incidence in the prevalence round as compared with the incidence rounds. According to the detection method the episode sensitivity increased with age from 57% in the age group 40-49 years to 84% in the age group 70-74 years. The corresponding figures for the incidence method were 50% and 77%, respectively. Conclusion Our study showed an interval cancer incidence of 38% and the episode sensitivity of 62-73%, depending on the method of calculation. Our results are of clinically acceptable level and concert with the reference values of the European guidelines.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 22 条
[1]  
Bjurstam N, 1997, CANCER, V80, P2091, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.3.CO
[2]  
2-F
[3]   Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden [J].
Bordas, P. ;
Jonsson, H. ;
Nystroem, L. ;
Lenner, P. .
BREAST, 2007, 16 (01) :47-54
[4]   Methodological issues in international comparison of interval breast cancers [J].
Bulliard, Jean-Luc ;
Sasieni, Peter ;
Klabunde, Carrie ;
De Landtsheer, Jean-Pierre ;
Yankaskas, Bonnie C. ;
Fracheboud, Jacques .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) :1158-1163
[5]  
Day N, 1995, J Med Screen, V2, P180
[6]   Interval cancers in the Dutch breast cancer screening programme [J].
Fracheboud, J ;
de Koning, HJ ;
Beemsterboer, PMM ;
Boer, R ;
Verbeek, ALM ;
Hendriks, JHCL ;
van Ineveld, BM ;
Broeders, MJM ;
de Bruyn, AE ;
van der Maas, PJ .
BRITISH JOURNAL OF CANCER, 1999, 81 (05) :912-917
[7]   ANALYSIS OF INTERVAL BREAST CARCINOMAS IN A RANDOMIZED SCREENING TRIAL IN STOCKHOLM [J].
FRISELL, J ;
EKLUND, G ;
HELLSTROM, L ;
SOMELL, A .
BREAST CANCER RESEARCH AND TREATMENT, 1987, 9 (03) :219-225
[8]   Sensitivity in cancer screening [J].
Hakama, Matti ;
Auvinen, Anssi ;
Day, Nicholas E. ;
Miller, Anthony B. .
JOURNAL OF MEDICAL SCREENING, 2007, 14 (04) :174-177
[9]   Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme [J].
Hofvind, Solveig ;
Bjurstam, Nils ;
Sorum, Ragnhild ;
Bjorndal, Hilde ;
Thoresen, Steinar ;
Skaane, Per .
JOURNAL OF MEDICAL SCREENING, 2006, 13 (04) :192-196
[10]   Radiological surveillance of interval breast cancers in screening programmes [J].
Houssami, N ;
Irwig, L ;
Ciatto, S .
LANCET ONCOLOGY, 2006, 7 (03) :259-265